GlassScriptPhysician profile
Brian F Chapin
NPI 1104952571
$27,308.93
in general payments reported to CMS, 2019-2025
17 companies · $2,219 in 2025
The $2,219 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,527 · 2020: $425 · 2021: $299 · 2022: $9,515 · 2023: $8,864 · 2024: $460 · 2025: $2,219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,220 · Food and Beverage: $2,068 · Honoraria: $1,000 · Travel and Lodging: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,220.00 |
| Food and Beverage | $2,068.30 |
| Honoraria | $1,000.00 |
| Travel and Lodging | $254.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $9,857.74 | 2019-2025 | Akeega, Erleada |
| Pfizer INC. | $7,033.03 | 2019-2025 | |
| Blue Earth Diagnostics | $4,125.30 | 2019-2024 | |
| Ethicon INC. | $2,525.00 | 2022 | |
| Janssen Biotech, INC. | $1,262.26 | 2019-2025 | Erleada, Balversa, Carvykti |
| Provepharm INC. | $1,080.03 | 2023 | Bludigo |
| Genzyme Corporation | $399.91 | 2019 | |
| Astellas Pharma US INC | $323.17 | 2020-2022 | |
| Boston Scientific Corporation | $259.60 | 2019-2023 | |
| Ethicon US, LLC | $164.72 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $133.09 | 2024 | Libtayo |
| Exelixis INC. | $40.29 | 2025 | Cabometyx |
| Myovant Sciences INC. | $30.17 | 2022 | |
| Cook Medical LLC | $25.00 | 2025 | Litho 150 |
| Ambu INC. | $19.23 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17.90 | 2020 | |
| Abbvie INC. | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Chapin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.